Showing results (61-70 of 143) with videos related to
Sort By:
Pageof 15
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 27, 2021
Adsorption of protein antigen to the cationic liposome adjuvant CAF®01 is required for induction of Th1 and Th17 responses but not for antibody inductionKatharina Wørzner, Jóhanna Hvannastein, Signe Tandrup Schmidt, et al.Vaccine|April 28, 2018
Immunological and physical evaluation of the multistage tuberculosis subunit vaccine candidate H56/CAF01 formulated as a spray-dried powderAneesh Thakur, Pall Thor Ingvarsson, Signe Tandrup Schmidt, et al.Journal De Pharmacie De Belgique|February 10, 2016
[The medication history: a tool to optimize the preoperative anesthesia consultation?]Anne-solène Monfort, Nadia Zerrouki, Baptiste Almecija, et al.Nanomedicine (London, England)|December 23, 2014
A stable nanoparticulate DDA/MMG formulation acts synergistically with CpG ODN 1826 to enhance the CD4⁺ T-cell responseKasper Karlsen, Karen Smith Korsholm, Rasmus Mortensen, et al.International Journal of Pharmaceutics|November 3, 2009
CAF01 liposomes as a mucosal vaccine adjuvant: In vitro and in vivo investigationsDennis Christensen, Camilla Foged, Ida Rosenkrands, et al.Biochimica Et Biophysica Acta|December 3, 2005
Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responsesJesper Davidsen, Ida Rosenkrands, Dennis Christensen, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|April 13, 2010
Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI responseMalou Henriksen-Lacey, Dennis Christensen, Vincent W Bramwell, et al.Molecular Pharmaceutics|December 2, 2010
Comparison of the depot effect and immunogenicity of liposomes based on dimethyldioctadecylammonium (DDA), 3β-[N-(N',N'-Dimethylaminoethane)carbomyl] cholesterol (DC-Chol), and 1,2-Dioleoyl-3-trimethylammonium propane (DOTAP): prolonged liposome retention mediates stronger Th1 responsesMalou Henriksen-Lacey, Dennis Christensen, Vincent W Bramwell, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|November 13, 2022
Oral vaccination using microdevices to deliver α-GalCer adjuvanted vaccine afford a mucosal immune responsePhilip H R Carlsen, Rolf Bech Kjeldsen, Gabriel K Pedersen, et al.Frontiers in Immunology|November 29, 2019
Corrigendum: Site-Specific DC Surface Signatures Influence CD4<sup>+</sup> T Cell Co-stimulation and Lung-HomingDavid Pejoski, Marie Ballester, Floriane Auderset, et al.Pageof 15